110 related articles for article (PubMed ID: 1913676)
1. ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.
Jackman AL; Taylor GA; Gibson W; Kimbell R; Brown M; Calvert AH; Judson IR; Hughes LR
Cancer Res; 1991 Oct; 51(20):5579-86. PubMed ID: 1913676
[TBL] [Abstract][Full Text] [Related]
2. Folic acid alleviates age-related cognitive decline and inhibits apoptosis of neurocytes in senescence-accelerated mouse prone 8: deoxythymidine triphosphate biosynthesis as a potential mechanism.
Zhou D; Lv X; Wang Y; Liu H; Luo S; Li W; Huang G
J Nutr Biochem; 2021 Nov; 97():108796. PubMed ID: 34102282
[TBL] [Abstract][Full Text] [Related]
3. Cooperative inhibition of human thymidylate synthase by mixtures of active site binding and allosteric inhibitors.
Lovelace LL; Gibson LM; Lebioda L
Biochemistry; 2007 Mar; 46(10):2823-30. PubMed ID: 17297914
[TBL] [Abstract][Full Text] [Related]
4. Rejection of reovirus-treated L1210 leukemia cells by mice.
Williams ME; Cox DC; Stevenson JR
Cancer Immunol Immunother; 1986; 23(2):87-92. PubMed ID: 2946408
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, molecular docking, and molecular dynamic studies of novel quinazoline derivatives as phosphodiesterase 7 inhibitors.
El-Malah AA; Gineinah MM; Khayat MT; Aljahdali AS; Safar MM; Almazmumi HA; Khinkar RM
Front Pharmacol; 2024; 15():1389076. PubMed ID: 38711988
[No Abstract] [Full Text] [Related]
6. Targeting one-carbon metabolism for cancer immunotherapy.
Ren X; Wang X; Zheng G; Wang S; Wang Q; Yuan M; Xu T; Xu J; Huang P; Ge M
Clin Transl Med; 2024 Jan; 14(1):e1521. PubMed ID: 38279895
[TBL] [Abstract][Full Text] [Related]
7. Targeting serine-glycine-one-carbon metabolism as a vulnerability in cancers.
Sun W; Liu R; Gao X; Lin Z; Tang H; Cui H; Zhao E
Biomark Res; 2023 May; 11(1):48. PubMed ID: 37147729
[TBL] [Abstract][Full Text] [Related]
8. Cardiotoxicity of Fluoropyrimidines: Epidemiology, Mechanisms, Diagnosis, and Management.
Jurczyk M; Król M; Midro A; Kurnik-Łucka M; Poniatowski A; Gil K
J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640443
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics in cancer research and emerging applications in clinical oncology.
Schmidt DR; Patel R; Kirsch DG; Lewis CA; Vander Heiden MG; Locasale JW
CA Cancer J Clin; 2021 Jul; 71(4):333-358. PubMed ID: 33982817
[TBL] [Abstract][Full Text] [Related]
10. The emerging relationship between metabolism and DNA repair.
Cucchi D; Gibson A; Martin SA
Cell Cycle; 2021 May; 20(10):943-959. PubMed ID: 33874857
[TBL] [Abstract][Full Text] [Related]
11. A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight.
Cuthbertson CR; Arabzada Z; Bankhead A; Kyani A; Neamati N
ACS Pharmacol Transl Sci; 2021 Apr; 4(2):624-646. PubMed ID: 33860190
[TBL] [Abstract][Full Text] [Related]
12. Raltitrexed-Modified Gold and Silver Nanoparticles for Targeted Cancer Therapy: Cytotoxicity Behavior In Vitro on A549 and HCT-116 Human Cancer Cells.
Morey J; Llinás P; Bueno-Costa A; León AJ; Piña MN
Materials (Basel); 2021 Jan; 14(3):. PubMed ID: 33499297
[TBL] [Abstract][Full Text] [Related]
13. A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells.
Marverti G; Gozzi G; Maretti E; Lauriola A; Severi L; Sacchetti F; Losi L; Pacifico S; Ferrari S; Ponterini G; Leo E; Costi MP; D'Arca D
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585842
[TBL] [Abstract][Full Text] [Related]
14. Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth.
Pacifico S; Santucci M; Luciani R; Saxena P; Linciano P; Ponterini G; Lauriola A; D'Arca D; Marverti G; Guerrini R; Costi MP
Molecules; 2019 Sep; 24(19):. PubMed ID: 31561530
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antimicrobial evaluation and docking studies of some novel quinazolinone Schiff base derivatives.
Nasab RR; Mansourian M; Hassanzadeh F
Res Pharm Sci; 2018 Jun; 13(3):213-221. PubMed ID: 29853931
[TBL] [Abstract][Full Text] [Related]
16. Docking study, synthesis and antimicrobial evaluation of some novel 4-anilinoquinazoline derivatives.
Nasab RR; Hassanzadeh F; Khodarahmi GA; Rostami M; Mirzaei M; Jahanian-Najafabadi A; Mansourian M
Res Pharm Sci; 2017 Oct; 12(5):425-433. PubMed ID: 28974981
[TBL] [Abstract][Full Text] [Related]
17. One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy.
Shuvalov O; Petukhov A; Daks A; Fedorova O; Vasileva E; Barlev NA
Oncotarget; 2017 Apr; 8(14):23955-23977. PubMed ID: 28177894
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma brucei DHFR-TS Revisited: Characterisation of a Bifunctional and Highly Unstable Recombinant Dihydrofolate Reductase-Thymidylate Synthase.
Gibson MW; Dewar S; Ong HB; Sienkiewicz N; Fairlamb AH
PLoS Negl Trop Dis; 2016 May; 10(5):e0004714. PubMed ID: 27175479
[TBL] [Abstract][Full Text] [Related]
19. TAS-102, a novel antitumor agent: a review of the mechanism of action.
Lenz HJ; Stintzing S; Loupakis F
Cancer Treat Rev; 2015 Nov; 41(9):777-83. PubMed ID: 26428513
[TBL] [Abstract][Full Text] [Related]
20. The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents.
Stivarou T; Cipolleschi MG; D'Amico M; Mannini A; Mini E; Rovida E; Dello Sbarba P; Olivotto M; Marzi I
Oncotarget; 2015 Oct; 6(31):31985-96. PubMed ID: 26396171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
